When was Hill Research founded?

Hill Research was founded in 2022 and raised its 1st funding round 4 years after it was founded.

Where is Hill Research located?

Hill Research is headquartered in Boston, United States.

Is Hill Research a funded company?

Hill Research is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 10, 2026.

When was the latest funding round of Hill Research?

Hill Research's latest funding was a $***** Seed round on Jul 01, 2026, with participation from 1 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.43B in funding in 2026 to date.

Where does Hill Research rank among its competitors?

Hill Research ranks 48th amongst 313 active competitors, of which 54 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Tempus, which secured $460M in Jul, 2026.

Who are the top competitors of Hill Research?

Hill Research's top competitors include Medidata, Verily and IQVIA. Among them, Tempus secured the most recent funding round in July, 2026.

Hill Research - 2026 Company Profile, Team, Funding & Competitors

Company Details

AI-powered solutions redefining clinical trials for faster, efficient pharmaceutical development. The company accelerates pharmaceutical development using Generative AI. They offer end-to-end AI-driven solutions, from trial design to regulatory submissions, including intelligent decision support, compliance optimization, and safety predictions. Powered by a multi-agent large language model (LLM) tree, they enable pharmaceutical companies to shorten clinical trial cycles and streamline operations. Their platform, TriClick, is an extensible agentic AI platform built to solve complex clinical data and documentation challenges, offering optimized workflows, unmatched accuracy, and robust data security. They provide data, software, and services to support critical functions from R&D through commercialization, leveraging AI and Natural Language Processing to transform data into actionable insights. This is a B2B, SaaS, and software company.

Key Metrics

Founded Year

2022

Location

Boston, United States

Stage

Seed

Latest Funding Round

Seed, Jul 01, 2026, $*****

Investors

Jetstream Venture Fund & 1 more

Ranked

48^th among 313 active competitors

Similar Companies

Medidata & 3178 more

View Hill Research's full profile

Hill Research has raised funding over 2 rounds. Its first funding round was on Apr 10, 2026. Its latest funding round was a Seed round on Jul 01, 2026 for $*****. 1 investor participated in its latest round. Hill Research has 2 institutional investors.

Here is the list of recent funding rounds of Hill Research:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 01, 2026	3794412	Seed	9108055	8104250	6923677	6607699
Apr 10, 2026	4567680	Seed	2985800	7477058	Jetstream Venture Fund	4949996

Access funding benchmarks and valuations. Sign up today!

View details of Hill Research's funding rounds and investors

The founders of Hill Research is Jack Li. Louise Liu is the CEO of Hill Research.

Here are the details of Hill Research's key team members:

Jack Li: Co-Founder & CTO of Hill Research.
Louise Liu: CEO of Hill Research.
Contact Info: 1 email address

View details of Hill Research's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Hill Research include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of Hill Research, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Medidata 1999, New York City (United States), Acquired	AI-based clinical trial management software for researchers	$41.5M	Insight Partners, TFS & 11 others	86/100
2nd	Verily 2015, Dallas (United States), Series D	A data platform and technology company purpose-built to power AI-enabled precision health	$2.8B	Silver Lake, Temasek & 9 others	82/100
3rd	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Aisling Capital ... & 12 others	79/100
4th	Tempus 2015, Chicago (United States), Public	Developer of genomic testing and artificial intelligence tools for medicine	$1.05B	T. Rowe Price, New Enterprise Associates ... & 11 others	77/100
5th	Signant Health 2000, Plymouth Meeting (United States), Acquired	Provider of a software solution for clinical trial management	$3.4M	Harvest Partners, 3i Group & 4 others	72/100
6th	Science 37 2014, Los Angeles (United States), Acquired	Provider of a suite solution for clinical trials for researchers	$106M	Redmile Group, Lux Capital & 12 others	71/100
7th	TriNetX 2013, Cambridge (United States), Acquired	Provider of clinical trial management software for researchers and professionals	$102M	Merck Global Health Innovation Fund, F2 Ventures ... & 6 others	66/100
8th	Wcg Clinical 2012, Princeton (United States), Acquired	CRO offering regulatory and ethical review services for clinical research	-	Ares Capital Corporation, Prospect Capital ... & 6 others	64/100
9th	Viz.ai 2016, San Francisco (United States), Series D	Developer of an AI-powered platform for care coordination and disease detection	$252M	Insight Partners, DHVC & 17 others	64/100
10th	Obvio Health 2015, Orlando (United States), Series B	Provider of clinical trials design and recruitment platform	$66M	Dedalus Group, Guardant Health & 13 others	62/100
48th	Hill Research 2022, Boston (United States), Seed	AI-powered solutions redefining clinical trials for faster, efficient pharmaceutical development	-	Jetstream Venture Fund, Covenant Venture Capital	41/100